Darin Weed

Experience

• 

  Minnesota State University, Mankato

  Jan 2007 - Jan 2011

  Intern

  -Assisted in an administrative role in a variety of scenarios.-Entered and presented relevant data to the research.-Followed chain of custody protocols for samples.

• 

  R&D Systems

  Jun 2010 - Aug 2010

  Intern

  -Characterized size exclusion chromatography elution of antibodies.-Developed a cleaning protocol to prolong the life of the columns, saving the company money.-Developed a protocol for handling atypical results, leading to the rejection of less products.

• 

  Le Sueur Cheese Company

  May 2011 - Jul 2012

  Head Laboratory Technician/Special Testing Lead

  -Managed the night shift of the 24 hour pharmaceutical lactose laboratory with the responsibility of production shutdown due to low product quality being my decision.-Followed SOP, GMP, and proper FDA documentation including OOS forms.-Managed all special testing projects for quality assurance and presented the results upon completion.-Wrote and developed an SOP for the testing of Staph enterotoxin using ELISA.-Obtained state certification in the testing of milk for bacterial colonies and antibiotics. Show less

• 

  Washington State University

  Aug 2012 - Dec 2018

  -Published primary research 1st author article in The Journal of Virology-Published book chapter review on Herpes Simplex Membrane Fusion in Springer reviews-Published 2nd 1st Author in the Journal of Virology-Utilized monoclonal antibodies towards herpes simplex virus glycoprotein B to determine virus is similarly neutralized in low-pH dependent and low-pH independent cell entry pathways-Characterized the antigenicity of HSV oligomeric change utilizing multiple antibodies.-Determined the threshold for reversibility of HSV gB conformation change has a similar pH threshold to that of conformational change-Identified that two glycoprotein C antibodies detect a conformational change following exposure of virions to acidic pH-Identified these same glycoprotein C antibodies preferentially inhibit entry into the low-pH dependent entry pathway of HSV, adding to our understanding of the differences between these pathways-Characterized the epitopes detected by a battery of glycoprotein C antibodies Show less

  • Postdoctoral Research Associate

    May 2018 - Dec 2018

  • PhD Research Assistant

    Aug 2012 - May 2018
• 

  GSK

  May 2014 - Aug 2014

  Microbiology laboratory assistant internship

  -My project consisted of creating a Streptococcus mutans biofilm on a CDC bioreactor within 24 hours of inoculation to model the oral cavity.-This project allowed the testing of oral care products efficacy against S. mutans.-In addition to laboratory work, I prepared a manuscript for publication of the bioreactor method.

• 

  University of North Carolina at Chapel Hill School of Medicine

  Jan 2019 - Apr 2020

  Postdoctoral Research Fellow at UNC Lineberger Comprehensive Cancer Center

  In the laboratory of Dr. Blossom Damania I studied KSHV innate immunity and pathogenesis.I applied high content screening (HCS) to identify host gene targets through high throughput siRNA screening. Analysis of large datasets through Cell Profiler and Excel were critical for optimizing and successfully implementing screens.I utilized RNA and DNA extraction, RT-qPCR, flow cytometry, lentivirus production and transduction, and many other molecular biology techniques to characterize proteins and pathways. Show less

• 

  Eva Garland Consulting, LLC

  Apr 2020 - Oct 2021

  Scientific Consultant | Grant Writing Specialist

  My primary role at EGC is to assist start-up companies in obtaining non-dilutive funding from federal agencies and non-profits. To succeed in this position, I utilize my strong written and oral communication skills to keep projects on time, coordinate with University partners and governmental funding agencies, and lead meetings to project manage both short and long-term goals.Understanding both drug and technology development and commercialization is essential in developing proposals that, if successful, will further advance the client's technology. Rapid understanding of new scientific fields is critical as new clients sign on regularly, and initial calls can occur within hours of being introduced to new clients. I help develop project scopes that fit within budgets for specific funding opportunities and have submitted grants totaling millions of dollars for clients. I provide expertise in scientific writing, editing, and overall scientific consulting to ensure client projects align with the goals of specific funding opportunities. I navigate and ultimately upload and submit grant applications through multiple government agency application portals.In my role, I also help develop non-dilutive strategic funding plans to aid in assisting clients in unlocking the $10 billion available in non-dilutive funding. Multiple clients have re-engaged for other grant writing supporting following the delivery and discussion of their non-dilutive funding plans. Show less

• 

  The Duke Human Vaccine Institute

  Nov 2021 - now

  • Scientific Program Leader II

    Apr 2024 - now

  • Scientific Program Leader I

    Nov 2021 - Apr 2024